e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pulmonary circulation III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension reduces exercise tolerance in COPD
I. Blanco, E. Gimeno, D. Rodriguez, J. Vilaro, S. Santos, R. Guell, J. Gea, J. Roca, J. A. Barbera (Barcelona, Spain)
Source:
Annual Congress 2010 - Pulmonary circulation III
Session:
Pulmonary circulation III
Session type:
Thematic Poster Session
Number:
1139
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Blanco, E. Gimeno, D. Rodriguez, J. Vilaro, S. Santos, R. Guell, J. Gea, J. Roca, J. A. Barbera (Barcelona, Spain). Pulmonary hypertension reduces exercise tolerance in COPD. Eur Respir J 2010; 36: Suppl. 54, 1139
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Pulmonary hypertension and exercise performance in advanced COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Exercise testing in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Exercise testing in pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Exercise testing in pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Exercise testing in pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Exercise testing in pulmonary hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Aerobic exercise capacity in COPD patients with and without pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Intermittent hypoxic training increases exercise tolerance in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008
Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Pulmonary haemodynamics during exercise in COPD
Source: International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit
Year: 2015
Contrasting cardiovascular responses to exercise in mitochondrial myopathy and pulmonary arterial hypertension
Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease
Year: 2016
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004
Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept